GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ARCT · Jun 30, 2026

Arcturus Therapeutics Holdings Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]

Inspectable configuration

State dimensions

Filing0001193125-26-338090General Corporate

Capex intensity15thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.00% · OPTIONAL · VALID

Operating cash generation25thOwn-history percentile · N=20

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-672.86% · OPTIONAL · VALID

Revenue growth5thOwn-history percentile · N=20

Evidence method

Yoy · gp.fundamentals.revenue

-89.54% · CORE · VALID

Operating margin25thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.operating_margin

-863.30% · CORE · VALID

R&D intensity75thOwn-history percentile · N=20

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

591.92% · OPTIONAL · VALID

SBC intensity80thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

142.99% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History25 statesSelf-history eligible

Period transition

What moved in the state?

Cash Generation Increased

Previous: -943.28%
Current: -672.86%
Delta: 270.42%

Growth Increased

Previous: -92.99%
Current: -89.54%
Delta: 3.44%

Profitability Increased

Previous: -1403.74%
Current: -863.30%
Delta: 540.44%

R And D Intensity Decreased

Previous: 1044.49%
Current: 591.92%
Delta: -452.57%

Sbc Intensity Decreased

Previous: 209.85%
Current: 142.99%
Delta: -66.86%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Mar 31, 2026

Similarity: 94%
Compared: 6 dimensions
Coverage: 100%

Growth 5.0 · Profitability 5.0 · Sbc Intensity 0.0 · Capex Intensity 5.0 · Cash Generation 10.0 · R And D Intensity 5.0

Sep 30, 2025

Similarity: 77%
Compared: 6 dimensions
Coverage: 100%

Growth 0.0 · Profitability 20.0 · Sbc Intensity 25.0 · Capex Intensity 25.0 · Cash Generation 25.0 · R And D Intensity 30.0

Jun 30, 2023

Similarity: 67%
Compared: 6 dimensions
Coverage: 100%

Growth 3.3 · Profitability 18.8 · Sbc Intensity 17.5 · Capex Intensity 1.7 · Cash Generation 75.0 · R And D Intensity 18.8

Dec 31, 2021

Similarity: 66%
Compared: 5 dimensions
Coverage: 83%

Profitability 5.0 · Sbc Intensity 10.0 · Capex Intensity 73.9 · Cash Generation 2.8 · R And D Intensity 5.0

Mar 31, 2025

Similarity: 63%
Compared: 6 dimensions
Coverage: 100%

Growth 21.3 · Profitability 45.0 · Sbc Intensity 55.0 · Capex Intensity 0.0 · Cash Generation 30.0 · R And D Intensity 45.0

Research Graph

Related governed research

Analogous To · ARCT state analogue 4 →Analogous To · ARCT state analogue 2 →Analogous To · ARCT state analogue 5 →Analogous To · ARCT state analogue 3 →Compared To · Pharmaceutical Preparations peers →Analogous To · ARCT state analogue 1 →Transitioned To · ARCT Fundamental State →Transitioned To · ARCT CASH_GENERATION_INCREASED →Transitioned To · ARCT GROWTH_INCREASED →Transitioned To · ARCT PROFITABILITY_INCREASED →Transitioned To · ARCT R_AND_D_INTENSITY_DECREASED →Transitioned To · ARCT SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.